Michelle F. Davis

(Bloomberg) -- Dyne Therapeutics Inc., a developer of drugs to treat muscle diseases, is considering options after receiving takeover interest from larger pharmaceutical companies, people with knowledge of the matter said.

(Bloomberg) -- Uniti Group Inc. is in talks to merge with telecommunications provider Windstream, according to people with knowledge of the matter.

Wells Fargo & Co. has hired Derek Van Zandt from Citigroup Inc. as head of media and telecommunications in its corporate and investment bank, according to people familiar with the matter.

A rush of megadeals is powering a rebound in mergers and acquisitions, bringing some much-needed relief for investment bankers after two years of subdued activity.

(Bloomberg) -- Three artificial intelligence companies that operate on blockchain have agreed to merge their crypto tokens, a move aimed at helping them develop a decentralized AI platform.

(Bloomberg) -- EuroLeague, the top tier of men's professional basketball in Europe, is exploring raising capital through the sale of a minority stake, Chief Executive Officer Paulius Motiejunas said.

(Bloomberg) -- Leerink Partners hired Rothschild & Co. managing director Timothy Hotchandani to focus on health-care dealmaking involving life-science

(Bloomberg) -- Alpine Immune Sciences Inc., a clinical-stage biotechnology company developing a treatment for inflammatory kidney diseases, is

(Bloomberg) -- Drugmaker Janux Therapeutics Inc. is exploring options, including a potential sale, after receiving takeover interest from larger pharmaceutical companies, people with knowledge of the matter said.

(Bloomberg) -- JPMorgan Chase & Co. has hired health-care banker Christopher Dass from Deutsche Bank AG as a managing director covering pharma-tech and pharma-services companies, according to people familiar with the matter.